Finally, even outside the brain, both pathogenic mutant LRRK2 mouse- and human PD patient-derived fibroblasts display impaired mitochondrial energetics, evidenced by decreased ATP and mitochondrial membrane potential and impaired mitochondrial Complex I and Complex IV function [69–72]. Here, LRRK2 is linked to Parkinson disease.